TORONTO, ONTARIO--(Marketwire - June 30, 2011) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
BioExx Specialty Proteins Ltd. (TSX:BXI) ("BioExx" or the "Company") announced today that it has closed its previously announced bought deal financing, sold by a syndicate of underwriters led by Canaccord Genuity Corp., and including Scotia Capital Inc., Wellington West Capital Markets Inc., and Stonecap Securities Inc. The financing consisted of 20,000,000 units ("Units") at a price of $1.00 per Unit for gross proceeds to BioExx of $20.0 million (the "Offering"). Each Unit consists of one common share of the Company and one half of one share purchase warrant, each whole warrant (the "Warrants") entitling the holder to acquire one additional common share of the Company at an exercise price of $1.50 for a period of 36 months, subject to early exercise upon notice by the Company to holders that the 20 day volume weighted average trading price of the Company's common shares on the TSX (or such other stock exchange that the Company's shares may then be listed on) is greater than $2.25. BioExx has also granted the underwriters an over-allotment option to purchase up to an additional 15% of the offered Units on the same terms and conditions, exercisable any time, in whole or in part, up to 30 days after the closing of the Offering, for additional gross proceeds of up to approximately $3.0 million.
About BioExx Specialty Proteins Ltd.
Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent- pending technologies that utilize significantly lower temperatures than conventional oilseed processing, in order to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.
To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com.
The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations.